• Markets
    • icon
  • Companies
PCK · ASX

PainChek Ltd (ASX:PCK)

AU$0.04

 0.004 (11.111%)
ASX:Live
26/07/2024 04:10:15 PM
Hammer Bearish HALO Price Momentum HALO Ords GROWTH AUS Big Candle +1
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

PCK Overview

PCK Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About PCK

Website

PainChek Ltd

Telephone

61.8.9388.8290

Address

Suite 401 35 Lime Street Sydney, New South Wales (NSW) 2000

Description

PainChek Ltd. engages in the development and commercialization of mobile medical device applications. The company was founded on August 27, 2010 and is headquartered in Sydney, Australia.

PCK Price Chart

Key Stats

Market Cap

AU$65.43M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.03 - 0.07

Trade Value (12mth)

AU$10,083.00

1 week

0%

1 month

28.57%

YTD

0%

1 year

28.57%

All time high

0.44

Key Fundamentals

EPS 3 yr Growth

-52.800%

EBITDA Margin

-448.60%

Operating Cashflow

-$6m

Free Cash Flow Return

-230.30%

ROIC

-275.90%

Interest Coverage

N/A

Quick Ratio

1.30

Other Data

Shares on Issue (Fully Dilluted)

1364m

HALO Sector

Technology

Next Company Report Date

28-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

PCK Announcements

Latest Announcements

Date Announcements

28 May 24

PainChek receives European patent for pain assessment tech

×

PainChek receives European patent for pain assessment tech

30 April 24

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

23 April 24

PainChek receives $1,210,000 R&D Tax Incentive Refund

×

PainChek receives $1,210,000 R&D Tax Incentive Refund

20 March 24

Application for quotation of securities - PCK

×

Application for quotation of securities - PCK

20 March 24

Notice under Section 708A(5)(e) of the Corporation Act 2001

×

Notice under Section 708A(5)(e) of the Corporation Act 2001

18 March 24

PCK to present at NWR Virtual Healthcare Conference

×

PCK to present at NWR Virtual Healthcare Conference

15 March 24

Change of Director's Interest Notices x5

×

Change of Director's Interest Notices x5

14 March 24

PainChek completes A$5m capital raise

×

PainChek completes A$5m capital raise

14 March 24

Update - Proposed issue of securities - PCK

×

Update - Proposed issue of securities - PCK

14 March 24

PainChek UK partnership with Nourish Care

×

PainChek UK partnership with Nourish Care

12 March 24

Trading Halt

×

Trading Halt

11 March 24

Completion of Security Purchase Plan

×

Completion of Security Purchase Plan

11 March 24

Application for quotation of securities - PCK

×

Application for quotation of securities - PCK

07 March 24

PainChek Share Purchase Plan oversubscribed

×

PainChek Share Purchase Plan oversubscribed

29 February 24

Half Yearly Report and Accounts

×

Half Yearly Report and Accounts

23 February 24

SPP & shareholder update webinar

×

SPP & shareholder update webinar

15 February 24

Notice under s7(f)(ii) of ASIC Corporations Instrument

×

Notice under s7(f)(ii) of ASIC Corporations Instrument

14 February 24

Underwritten Share Purchase Plan to raise AUD $2.5 million

×

Underwritten Share Purchase Plan to raise AUD $2.5 million

14 February 24

Proposed issue of securities - PCK

×

Proposed issue of securities - PCK

14 February 24

Update - Proposed issue of securities - PCK

×

Update - Proposed issue of securities - PCK

12 February 24

Trading Halt

×

Trading Halt

30 January 24

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

30 January 24

Investor Webinar Presentation

×

Investor Webinar Presentation

29 January 24

Quarterly Investor Webinar

×

Quarterly Investor Webinar

19 January 24

Notification of cessation of securities - PCK

×

Notification of cessation of securities - PCK

PCK Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 56.8 5.6 -15.7 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.00 -0.00 -0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.00 -0.01 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock -41.4 7.9 -21.3 Lock Lock Lock
     Yield % Lock Lock Lock Lock -6.4 -22.2 -19.6 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.01 0.00 0.00 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.01 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 83.5 -44.7 -87.2 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 1,116 1,128 1,290 Lock Lock Lock
Basic m Lock Lock Lock Lock 1,116 1,128 1,290 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 0 1 2 Lock Lock Lock
     Growth % Lock Lock Lock Lock -13.5 355.6 99.2 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 9 7 9 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 0 0 1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -2,398.5 39.0 375.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -197.5 -26.4 36.5 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 297 126 63 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -9 -8 -9 Lock Lock Lock
     Growth % Lock Lock Lock Lock 40.6 15.0 -15.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock -4,148.0 -774.1 -448.6 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -9 -8 -9 Lock Lock Lock
     Growth % Lock Lock Lock Lock 40.4 15.4 -15.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock -4,175.7 -775.6 -449.4 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -7 -7 -9 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -1 -1 -1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -6 -6 -8 Lock Lock Lock
     Growth % Lock Lock Lock Lock 51.1 5.7 -32.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock -2,823.0 -584.6 -388.5 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -4 -7 -6 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 9 2 3 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -4 -7 -6 Lock Lock Lock
     Growth % Lock Lock Lock Lock -116.4 -67.9 9.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -19.5 -7.2 -3.3 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 11 6 3 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 12 7 3 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -11 -6 -3 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 4 2 2 Lock Lock Lock
Equity $m Lock Lock Lock Lock 8 5 1 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 8 5 1 Lock Lock Lock
     Growth % Lock Lock Lock Lock 99.7 -41.5 -86.1 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -51.3 -86.0 -271.0 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -73.5 -118.6 -1,133.7 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -145.0 -116.2 -319.1 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -98.0 -87.6 -275.9 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -66.6 -107.1 -230.3 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 1.3 0.8 0.3 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -138.5 -127.3 -376.0 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 3.3 3.6 1.3 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 3.3 3.6 1.3 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 96.8 92.7 90.6 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -115.5 -382.6 -297.3 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 1.1 2.6 6.1 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.2 3.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 151.4 28.2 25.6 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.1 0.7 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.1 0.7 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -3,315.7 -696.2 -442.3 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -60.3 -102.4 -308.5 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -51.3 -86.0 -271.0 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.4 1.4 4.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -73.5 -118.6 -1,133.7 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -73.5 -118.6 -1,133.7 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 327.0 140.4 59.8 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 327.0 140.4 59.8 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 158.9 88.6 114.2 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 168.1 51.8 -54.4 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

%

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

PCK Shortsell

Frequently Asked Questions

The current share price of PainChek Ltd (PCK:ASX) is AU$0.04.
The 52-week high share price for PainChek Ltd (PCK:ASX) is AU$0.07.
The 52-week low share price for PainChek Ltd (PCK:ASX)? is AU$0.03.
PainChek Ltd (PCK:ASX) does not pay a dividend.
PainChek Ltd (PCK:ASX) does not pay a dividend.
PainChek Ltd (PCK:ASX) does not offer franking credits.
PainChek Ltd (PCK:ASX) is classified in the Technology.
The current P/E ratio for PainChek Ltd (PCK:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.